Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payload platform with potential impact ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Board member since March 2023 Nationality: British/American | Year of birth: 1964 A scientist by training, John D. Young has over 35 years of experience in the healthcare industry and brings a wealth ...
Transforming the treatment and healthcare system landscape using early interventions, pioneering treatments, and innovative partnerships to avoid preventable mortality from cardiovascular disease (CVD ...
Join our network of bright and curious minds What makes building a career here so rewarding? It’s being part of a community of smart, dedicated people. Professionals you can admire, learn from, and ...
Novartis uses the open-source Drupal content management framework for many key websites, including our flagship global site Novartis.com, main country sites, portals for healthcare professionals, and ...
노바티스의 성과 지향 문화와 책임 있는 비즈니스 방식은 연구개발, 마케팅 및 영업, 재무 및 운영 등 다양한 분야의 최고 전문가들을 영입할 수 있는 핵심 요소입니다. 노바티스를 헬스케어 분야의 글로벌 선두주자로 이끈 것은 바로 우리의 인재들입니다. 노바티스는 자신의 아이디어와 시간을 ...
Basel, July 2, 2026 – Novartis today announced that the European Commission (EC) has approved Itvisma ® (onasemnogene ...
Die lokale Geschäftseinheit ist für die Vermarktung von rund 75 verschreibungspflichtigen Medikamenten in der Schweiz verantwortlich. Zu den wichtigsten Therapiegebieten gehören Onkologie, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results